Penumbra’s Thunderbolt device receives FDA clearance

▤ Summary

Penumbra received FDA clearance for THUNDERBOLT, a device that expands its computer-assisted vacuum thrombectomy technology for acute ischemic stroke. The product uses modulated aspiration to improve clot capture and reduce catheter manipulation during stroke treatment. Penumbra positions THUNDERBOLT as the only CAVT device available for stroke treatment in the U.S. The launch reinforces Penumbra’s broader neurovascular strategy and its push to improve outcomes in urgent stroke care.

▦ Linked Companies